Treatment of major aortic graft infection: Preliminary experience with total graft excision and in situ replacement with a rifampicin bonded prosthesis by Naylor, Ross et al.
Citation: Naylor, Ross, Clark, Stephen, London, Nicholas, Sayers, Rob, Macpherson, D. S., 
Barrie, W. W. and Bell, Peter (1995) Treatment of major aortic graft infection: Preliminary 
experience  with  total  graft  excision  and  in  situ  replacement  with  a  rifampicin  bonded 
prosthesis. European Journal of Vascular and Endovascular Surgery, 9 (2).  pp. 252-256. 
ISSN 1078 5884 
Published by: Elsevier
URL:  http://dx.doi.org/10.1016/S1078-5884(05)80101-7  <http://dx.doi.org/10.1016/S1078-
5884(05)80101-7>
This  version  was  downloaded  from  Northumbria  Research  Link: 
http://nrl.northumbria.ac.uk/22252/
Northumbria University has developed Northumbria Research Link (NRL) to enable users to 
access the University’s research output. Copyright © and moral rights for items on NRL are 
retained by the individual author(s) and/or other copyright owners.  Single copies of full items 
can be reproduced,  displayed or  performed,  and given to  third parties in  any format  or 
medium for personal research or study, educational, or not-for-profit purposes without prior 
permission or charge, provided the authors, title and full bibliographic details are given, as 
well  as a hyperlink and/or URL to the original metadata page. The content must  not  be 
changed in any way. Full items must not be sold commercially in any format or medium 
without  formal  permission  of  the  copyright  holder.   The  full  policy  is  available  online: 
http://nrl.northumbria.ac.uk/policies.html
This document may differ from the final, published version of the research and has been 
made available online in accordance with publisher policies. To read and/or cite from the 
published version of the research, please visit the publisher’s website (a subscription may be 
required.)
Eur J Vasc Endovasc Surg (1995) 9, 252-256 
Treatment of Major Aortic Graft Infection: Preliminary Experience 
with Total Graft Excision and In Situ Replacement with a Rifampicin 
Bonded Prosthesis 
A.R. Naylor 1, S. Clark 1, N.J.M. London ~, R.D. Sayers ~, D.S. Macpherson 2, W.W. Barrie2and 
P.R.F. BelP 
Departments of 1Vascular Surgery at Leicester Royal Infirmary and 2Leicester General Hospital, Leicester, U.K. 
Key Words: Aortic graft infection; Rifampicin. 
Introduction Clinical Materials 
The most feared complication after aortic reconstruc- 
tion is infection, principally because the ensuing death 
and/or  amputation rate may exceed 70%. 1 Its relative 
rarity (1-2%) 1' 2 has contributed towards problems in 
determining the optimal mode of management 
because thousands of patients would be required in 
prospective trials to prove the effectiveness of one 
treatment regime over another. Accordingly the lit- 
erature contains genuine claims and counter-claims on 
the respective merits of antibiotic irrigation, total graft 
excision, extra-anatomical bypass, autologous recon- 
struction, in situ prosthetic revascularisation or retro- 
peritoneal in-line prosthetic bypass. 3-7 
Until recently, it had been our policy to excise 
infected aortic prostheses and undertake synchronous 
extra-anatomic bypass. However we were then faced 
with a patient with an infected aortic graft, massive 
retroperitoneal abscess formation and poor peripheral 
perfusion in whom flexion deformities at the hips 
precluded extra-anatomical bypass. We therefore 
undertook to manage this patient by graft excision 
and in situ replacement with a rifampicin bonded 
prosthesis as had been recently advocated by Stra- 
chan. 8 Impressed with the outcome, we have since 
dealt with four further patients in a similar manner. 
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Patients were commenced on parenteral antibiotics 
(cefuroxime and metronidazole) once the diagnosis of 
graft infection was suspected and each received a 
further bolus with induction of anaesthesia. Preopera- 
tive CT scans and angiograms were performed rou- 
tinely unless clinical urgency precluded them. At the 
time of undertaking this study there were no MRI 
facilities at this hospital. At operation, the aorto-iliac 
segments were mobilised and any macroscopically 
infected tissue debrided. The original graft was then 
excised and replaced with a rifampicin-bonded pros- 
thesis in the manner described by Strachan. 8 In 
summary, a 20ml ampoule containing 600mg of 
rifampicin (Merrell Dow) was reconstituted with 10ml 
of solvent provided. The resultant solution was added 
to a kidney dish into which was placed a pre-prepared 
and sized gelatin impregnated, knitted Dacron graft 
(Gelsoft, Vascutek Ltd, UK) and lavaged for ten 
minutes in order to ensure complete bonding of the 
antibiotic to the gelatin coating. The prosthesis was 
then anastomosed in the standard manner and cov- 
ered with an omental pedicle where possible. Post- 
operatively, all patients were continued on parenteral 
and then oral antibiotics (usually cefuroxime or 
ciprofloxacillin and metronidazole) for 6 weeks. The 
exact choice depended on micro-organism sensitivities 
and patient allergies. The decision to stop antibiotic 
therapy at 6 weeks was based on pre-existing unit 
policy when all patients had been reviewed and there 
was no clinical evidence of residual infection. In 
additiqn, each patient underwent a III Indium labelled 
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